Proteomic and functional comparison between human induced and embryonic stem cells
Open Access
- 14 November 2024
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Abstract
Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.Keywords
All Related Versions
Funding Information
- Wellcome Trust (098503/E/12/Z)
- Wellcome Trust (10.35802/073980)
- Biotechnology and Biological Sciences Research Council (BB/V010948/1)
- Engineering and Physical Sciences Research Council (EP/Y010655/1)
- Wellcome Trust (10.35802/097418)
- Wellcome Trust (10.35802/105024)
- Wellcome Trust (10.35802/205023)
- Wellcome Trust (206293/Z/17/Z)
This publication has 75 references indexed in Scilit:
- FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequencesInternational Journal of Cancer, 2019
- High-Resolution FluoRespirometry and OXPHOS Protocols for Human Cells, Permeabilized Fibers from Small Biopsies of Muscle, and Isolated Mitochondria2018
- Glutamine transporters in mammalian cells and their functions in physiology and cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- TGF-β: A Master of All T Cell TradesCell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Role of linker histone in chromatin structure and function: H1 stoichiometry and nucleosome repeat lengthChromosome Research, 2006
- TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillanceCancer Cell, 2005
- Phosphorylation and Functional Inactivation of TSC2 by ErkCell, 2005
- SREBP transcription factors: master regulators of lipid homeostasisBiochimie, 2004